Official Title: “Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation”

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Study Type: Interventional

Study Design: Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Intervention(s) in this Clinical Trial

• Behavioral: follow-up rehabilitation of participants with COPD

Primary Measures

• Disease specific Quality of Life
• Work Capacity

Secondary Measures

• Number of days admitted to hospital

Inclusion Criteria:

• FEV1 < 60% of expected

Exclusion Criteria:

• Other severe chronic conditions

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Sponsor: Glostrup University Hospital,Copenhagen

Overall Clinical Trial Officials and Contacts

Susanne Vest, MD Principal Investigator Glostrup University Hospital,Copenhagen  

Overall Contact: Susanne Vest, MD  susanne.vest@dadlnet.dk

Information obtained from ClinicalTrials.gov on November 20, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00419289

Study ID Number: KA20060179

ClinicalTrials.gov Identifier: NCT00419289

Health Authority: Denmark: Ethics Committee